KMVAX | VEXAX | KMVAX / VEXAX | |
Total Expense Ratio | 1.35 | 0.05 | 2,700% |
Annual Report Gross Expense Ratio | 1.35 | 0.05 | 2,700% |
Fund Existence | 27 years | 25 years | - |
Gain YTD | 19.511 | 10.112 | 193% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 115M | 83.7B | 0% |
Annual Yield % from dividends | 0.00 | 1.10 | - |
Returns for 1 year | 12.54 | 11.65 | 108% |
Returns for 3 years | 68.96 | 58.64 | 118% |
Returns for 5 years | 89.07 | 52.04 | 171% |
Returns for 10 years | 70.53 | 152.21 | 46% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PHPSX | 23.06 | 0.10 | +0.44% |
ProFunds Pharmaceuticals UltraSector Svc | |||
LMPEX | 28.53 | 0.10 | +0.35% |
Franklin Global Equity 1 | |||
FBSOX | 50.53 | N/A | N/A |
Fidelity Select Enterprise Tech Svcs | |||
AMIDX | 15.28 | N/A | N/A |
Amana Developing World Institutional | |||
KAUAX | 6.17 | -0.01 | -0.16% |
Federated Hermes Kaufmann A |